Versatile biomanufacturing through stimulus-responsive cell–material feedback
暂无分享,去创建一个
Lingchong You | Ashutosh Chilkoti | Zhuojun Dai | Stefan Roberts | Shuqiang Huang | Zihe Liu | L. You | A. Chilkoti | T. Sysoeva | Zhuojun Dai | Shuqiang Huang | Zihe Liu | Michael Dzuricky | Anna J. Lee | Tatyana A. Sysoeva | Xiaoyu Yang | Xi Zhang | Xi Zhang | S. Roberts | A. J. Lee | Xiaoyu Yang | Michael J Dzuricky
[1] A. Chilkoti,et al. Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose control , 2013, Proceedings of the National Academy of Sciences.
[2] Karan Sukhija,et al. A Single-use Strategy to Enable Manufacturing of Affordable Biologics , 2016, Computational and structural biotechnology journal.
[3] R. Fleischmann,et al. High quality protein microarray using in situ protein purification , 2009, BMC biotechnology.
[4] L. Tsimring,et al. A stabilized microbial ecosystem of self-limiting bacteria using synthetic quorum-regulated lysis , 2017, Nature Microbiology.
[5] J. Mecsas,et al. Bacterial Secretion Systems: An Overview , 2016, Microbiology spectrum.
[6] Huub Schellekens,et al. Making individualized drugs a reality , 2017, Nature Biotechnology.
[7] Nicolas E. Buchler,et al. Programming stress-induced altruistic death in engineered bacteria , 2012, Molecular systems biology.
[8] James J. Collins,et al. Portable, On-Demand Biomolecular Manufacturing , 2016, Cell.
[9] A. Kjøniksen,et al. Effects of ionic strength on the size and compactness of chitosan nanoparticles , 2012, Colloid and Polymer Science.
[10] J. Cronan,et al. The Burkholderia cenocepacia BDSF quorum sensing fatty acid is synthesized by a bifunctional crotonase homologue having both dehydratase and thioesterase activities , 2012, Molecular microbiology.
[11] S. Quake,et al. Long-Term Monitoring of Bacteria Undergoing Programmed Population Control in a Microchemostat , 2005, Science.
[12] Nigel Allison,et al. Current status and future trends for disposable technology in the biopharmaceutical industry , 2014 .
[13] M. Omar Din,et al. Synchronized cycles of bacterial lysis for in vivo delivery , 2016, Nature.
[14] M. Burkart,et al. Mechanism-based protein cross-linking probes to investigate carrier protein-mediated biosynthesis. , 2006, ACS chemical biology.
[15] A. Gutowska,et al. Squeezing hydrogels for controlled oral drug delivery , 1997 .
[16] Florian David,et al. Reprogramming Yeast Metabolism from Alcoholic Fermentation to Lipogenesis , 2018, Cell.
[17] E. Redwan,et al. Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives. , 2015, Journal of microbiology and biotechnology.
[18] X Huang,et al. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[19] D. Needham,et al. Investigation of the Swelling Response and Loading of Ionic Microgels with Drugs and Proteins: The Dependence on Cross-Link Density , 1999 .
[20] Alan Dove,et al. Uncorking the biomanufacturing bottleneck , 2002, Nature Biotechnology.
[21] C. Collins,et al. Modular optimization of multi-gene pathways for fatty acids production in E. coli , 2013, Nature Communications.
[22] Kurt Brorson,et al. The need for innovation in biomanufacturing , 2012, Nature Biotechnology.
[23] S. Kubick,et al. A Continuous-Exchange Cell-Free Protein Synthesis System Based on Extracts from Cultured Insect Cells , 2014, PloS one.
[24] R. Heath,et al. Enoyl-Acyl Carrier Protein Reductase (fabI) Plays a Determinant Role in Completing Cycles of Fatty Acid Elongation in Escherichia coli(*) , 1995, The Journal of Biological Chemistry.
[25] Tingrui Pan,et al. Synthetic microbial consortia enable rapid assembly of pure translation machinery. , 2018, Nature chemical biology.
[26] F. Arnold,et al. Synthesis of bioactive protein hydrogels by genetically encoded SpyTag-SpyCatcher chemistry , 2014, Proceedings of the National Academy of Sciences.
[27] B. Seijo,et al. Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. , 2005, Journal of colloid and interface science.
[28] Adriana G. Lopes,et al. Single-use in the biopharmaceutical industry: A review of current technology impact, challenges and limitations , 2015 .
[29] A. Ashok,et al. Improving cold chain systems: Challenges and solutions. , 2017, Vaccine.
[30] F. Mergulhão,et al. Secretion Capacity Limitations of the Sec Pathway in Escherichia coli , 2004 .
[31] Benjamin C. Tang,et al. Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery. , 2013, ACS nano.
[32] Ashutosh Chilkoti,et al. Purification of recombinant proteins by fusion with thermally-responsive polypeptides , 1999, Nature Biotechnology.
[33] David K. Karig,et al. Metabolic division of labor in microbial systems , 2018, Proceedings of the National Academy of Sciences.
[34] M. Rotondi,et al. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. , 2000, The Journal of clinical endocrinology and metabolism.
[35] David K. Karig,et al. Preservation of protein expression systems at elevated temperatures for portable therapeutic production , 2017, Journal of The Royal Society Interface.
[36] D. Kohane,et al. HYDROGELS IN DRUG DELIVERY: PROGRESS AND CHALLENGES , 2008 .
[37] Gary Walsh,et al. Biopharmaceutical benchmarks 2014 , 2014, Nature Biotechnology.
[38] Paul Yager,et al. Cell lysis and protein extraction in a microfluidic device with detection by a fluorogenic enzyme assay. , 2002, Analytical chemistry.
[39] A. Chilkoti,et al. Purification of an elastin‐like fusion protein by microfiltration , 2006, Biotechnology and bioengineering.
[40] Joseph D Puglisi,et al. Quantitative polysome analysis identifies limitations in bacterial cell-free protein synthesis. , 2005, Biotechnology and bioengineering.
[41] D. Summers,et al. Recombinant protein secretion in Escherichia coli. , 2005, Biotechnology advances.
[42] Tiangang Liu,et al. In vitro reconstitution and steady-state analysis of the fatty acid synthase from Escherichia coli , 2011, Proceedings of the National Academy of Sciences.
[43] Timothy K Lu,et al. Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care , 2016, Nature Communications.
[44] Lingchong You,et al. Coupling spatial segregation with synthetic circuits to control bacterial survival , 2016, Molecular systems biology.
[45] Yu Tanouchi,et al. Oscillations by Minimal Bacterial Suicide Circuits Reveal Hidden Facets of Host-Circuit Physiology , 2010, PloS one.
[46] Uwe Gottschalk,et al. Single-use disposable technologies for biopharmaceutical manufacturing. , 2013, Trends in biotechnology.
[47] James J. Collins,et al. Paper-Based Synthetic Gene Networks , 2014, Cell.
[48] L. You,et al. Synthetic Biology Looks Good on Paper , 2014, Cell.
[49] C. Bewley,et al. Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential , 2016, Viruses.
[50] Patient-centered drug manufacture , 2017, Nature Biotechnology.
[51] L. Thöny-Meyer,et al. Production of glycoprotein vaccines in Escherichia coli , 2010, Microbial cell factories.
[52] David K. Karig,et al. Antibiotics as a selective driver for conjugation dynamics , 2016, Nature Microbiology.
[53] Geoffrey S F Ling,et al. Battlefield Medicine: Paradigm Shift for Pharmaceuticals Manufacturing , 2014, PDA Journal of Pharmaceutical Science and Technology.